Medical Services | Addiction Professional Magazine Skip to content Skip to navigation

Medical Services

FDA seeks to encourage development of abuse-deterrent opioid formulations

November 24, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Head of FDA has harsh words about kratom use

November 17, 2017  |  Gary A. Enos, Editor
article
A public health advisory issued this week by the Food and Drug Administration (FDA) has re-intensified controversy over use of the plant-based product kratom.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
article
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Record-setting amount of prescriptions collected on Take Back Day

November 7, 2017  |  Tom Valentino, Senior Editor
news
More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.

Injectable buprenorphine moves closer to approval

November 2, 2017  |  Gary A. Enos, Editor
news
It appears likely that the first monthly injectable formulation of buprenorphine to treat opioid dependence will receive federal approval by the end of this month.

Studies capture challenges in reaching rescued patients

October 30, 2017  |  Gary A. Enos, Editor
article
Research released today at the American College of Emergency Physicians' annual meeting demonstrates the complexities of achieving positive outcomes with patients rescued from an opioid overdose.

Fact sheet on opioid treatments targets justice officials

October 27, 2017  |  Gary A. Enos, Editor
article
The American Association for the Treatment of Opioid Dependence (AATOD) seeks to separate ideology from evidence in discussing the importance of medication treatments in the justice system.

Insurers track adherence to CDC opioid guidelines

October 23, 2017  |  Julie Miller, Editor in Chief
article
Data is the one thing that managed care has in spades. And now the health plan industry is using that data to help prevent opioid misuse.

Lakeview Health launches pain recovery program

October 11, 2017  |  Gary A. Enos, Editor
news
The Florida facility's new service for patients experiencing addiction and chronic pain will include a process group focused on pain recovery and peer support.

Pages

Subscribe to Medical Services